Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Leukemia
|
June 28, 2018
Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas
Eleni Anastasiadou, Dina Stroopinsky, Stella Alimperti, et al.
Haematologica
|
February 4, 2021
Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia model
Dina Stroopinsky, Jessica Liegel, Manoj Bhasin, et al.
Cell Research
|
April 27, 2019
Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy
Vera Mugoni, Riccardo Panella, Giulia Cheloni, et al.
Blood Advances
|
August 14, 2025
Vaccine-Educated T cells and a CD123 Bispecific T-Cell Engager for Treatment of Acute Myeloid Leukemia
Jessica Liegel, Dina Stroopinsky, Giulia Cheloni, et al.
Blood
|
January 28, 2017
MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia
Athalia Rachel Pyzer, Dina Stroopinsky, Hasan Rajabi, et al.
Blood
|
March 2, 2023
Phase 2 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease
Anita G Koshy, Haesook T Kim, Jessica Liegel, et al.
Cancer Research Communications
|
October 24, 2025
A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies
Dejan Juric, Daniel Anderson, Afshin Dowlati, et al.
Science Translational Medicine
|
December 8, 2021
Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence
Afroditi Katsarou, Maria Sjöstrand, Jyoti Naik, et al.
Science Translational Medicine
|
December 9, 2016
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions
Jacalyn Rosenblatt, Richard M Stone, Lynne Uhl, et al.
Blood
|
March 18, 2018
Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease
Myrna R Nahas, Robert J Soiffer, Haesook T Kim, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Leukemia
|
June 28, 2018
Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas
Eleni Anastasiadou, Dina Stroopinsky, Stella Alimperti, et al.
Haematologica
|
February 4, 2021
Leukemia vaccine overcomes limitations of checkpoint blockade by evoking clonal T cell responses in a murine acute myeloid leukemia model
Dina Stroopinsky, Jessica Liegel, Manoj Bhasin, et al.
Cell Research
|
April 27, 2019
Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy
Vera Mugoni, Riccardo Panella, Giulia Cheloni, et al.
Blood Advances
|
August 14, 2025
Vaccine-Educated T cells and a CD123 Bispecific T-Cell Engager for Treatment of Acute Myeloid Leukemia
Jessica Liegel, Dina Stroopinsky, Giulia Cheloni, et al.
Blood
|
January 28, 2017
MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia
Athalia Rachel Pyzer, Dina Stroopinsky, Hasan Rajabi, et al.
Blood
|
March 2, 2023
Phase 2 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease
Anita G Koshy, Haesook T Kim, Jessica Liegel, et al.
Cancer Research Communications
|
October 24, 2025
A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies
Dejan Juric, Daniel Anderson, Afshin Dowlati, et al.
Science Translational Medicine
|
December 8, 2021
Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence
Afroditi Katsarou, Maria Sjöstrand, Jyoti Naik, et al.
Science Translational Medicine
|
December 9, 2016
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions
Jacalyn Rosenblatt, Richard M Stone, Lynne Uhl, et al.
Blood
|
March 18, 2018
Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease
Myrna R Nahas, Robert J Soiffer, Haesook T Kim, et al.
Page
of 4